サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1416338

一酸化窒素吸入市場レポート：2030年までの動向、予測、競合分析

Inhaled Nitric Oxide Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日: | 発行: Lucintel | ページ情報: 英文 150 - page report | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.90円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

一酸化窒素吸入市場レポート：2030年までの動向、予測、競合分析
出版日: 2024年01月29日
発行: Lucintel
ページ情報: 英文 150 - page report
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

吸入一酸化窒素の動向と予測

世界の吸入一酸化窒素市場は、2024年から2030年までのCAGRが5.1%で、2030年までに推定11億米ドルに達すると予想されています。この市場の主な促進要因は、進行中の研究開発活動に加え、呼吸器疾患およびその他の関連疾患の有病率の増加です。世界の吸入一酸化窒素市場の将来は、新生児呼吸器治療、喘息とCOPD、急性呼吸窮迫症候群、マラリア治療、結核治療市場での機会があり、有望に見えます。

吸入一酸化窒素市場に関する洞察

Lucintelは、コンパクトでポータブルな送達システムのイントロダクションより、送達システムは予測期間中にさらに高い成長を遂げると予測しています。これにより、さまざまなヘルスケア用途で一酸化窒素療法の投与が容易になります。

この市場の中で、喘息とCOPDは、喘息とCOPDの症状の一因となるタバコの消費量の増加により、最も高い成長を遂げると予想されています。

北米は、 COPDや喘息などの病気の発生率の急増、高齢化人口の増加、この地域における主要な保険会社の存在により、予測期間中に最高の成長を遂げると予想されています。

よくある質問

Q1.市場規模は：

A1.世界の吸入一酸化窒素市場は、2030年までに推定11億米ドルに達すると予想されています。

Q2.市場の成長予測は：

A2.世界の吸入一酸化窒素市場は、2024年から2030年にかけて5.1%のCAGRで成長すると予想されています。

Q3.市場の成長に影響を与える主な促進要因は：

A3.この市場の主な促進要因は、進行中の研究開発活動に加えて、呼吸器疾患およびその他の関連疾患の有病率の増加です。

Q4.市場の主要セグメントは：

A4.吸入一酸化窒素市場の将来は、新生児呼吸器治療、喘息とCOPD、急性呼吸窮迫症候群、マラリア治療、結核治療市場での機会があり、有望に見えます。

Q5.市場の主要企業は：

A5.主要な吸入一酸化窒素会社は次のとおりです。

  • Air Liquide Healthcare
  • BOC Healthcare
  • Matheson Tri-Gas
  • Merck
  • Mallinckrodt Pharmaceuticals
  • Nu-Med Plus
  • Perma Pure

Q6.今後、最大となる市場セグメントは：

A6.Lucintelは、コンパクトでポータブルな送達システムのイントロダクションより、送達システムは予測期間中にさらに高い成長を遂げると予測しています。これにより、さまざまなヘルスケア用途で一酸化窒素療法の投与が容易になります。

Q7.市場において、今後5年間に最大になると予想される地域は：

A7.北米は、 COPDや喘息などの病気の発生率の急増、高齢化人口の増加、この地域における主要な保険会社の存在により、予測期間中に最高の成長を遂げると予想されています。

Q8.レポートのカスタマイズは可能か：

A8.はい、Lucintelは追加費用なしで10%のカスタマイズを提供します。

目次

第1章 エグゼクティブサマリー

第2章 世界の吸入一酸化窒素市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界の吸入一酸化窒素市場動向（2018-2023）と予測（2024-2030）
  • 製品タイプ別の世界の吸入一酸化窒素市場
    • ガス
    • 配送システム
  • アプリケーション別の世界の吸入一酸化窒素市場
    • 新生児呼吸器治療
    • 喘息とCOPD
    • 急性呼吸促拍症候群
    • マラリア治療
    • 結核の治療
    • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

  • 地域別の世界の吸入一酸化窒素市場
  • 北米の吸入一酸化窒素市場
  • 欧州の吸入一酸化窒素市場
  • アジア太平洋地域の吸入一酸化窒素市場
  • その他地域吸入一酸化窒素市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • 製品タイプ別の世界の吸入一酸化窒素市場の成長機会
    • アプリケーション別の世界の吸入一酸化窒素市場の成長機会
    • 地域別の世界の吸入一酸化窒素市場の成長機会
  • 世界の吸入一酸化窒素市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界の吸入一酸化窒素市場の生産能力の拡大
    • 世界の吸入一酸化窒素市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • Air Liquide Healthcare
  • BOC Healthcare
  • Matheson Tri-Gas
  • Merck
  • Mallinckrodt Pharmaceuticals
  • Nu-Med Plus
  • Perma Pure
目次

Inhaled Nitric Oxide Trends and Forecast

The future of the global inhaled nitric oxide market looks promising with opportunities in the neonatal respiratory treatment, asthma and COPD, acute respiratory distress syndrome, malaria treatment, and tuberculosis treatment markets. The global inhaled nitric oxide market is expected to reach an estimated $1.1 billion by 2030 with a CAGR of 5.1% from 2024 to 2030. The major drivers for this market are increasing prevalence of respiratory and other associated diseases along with ongoing research and development activities.

A more than 150-page report is developed to help in your business decisions.

Inhaled Nitric Oxide by Segment

The study includes a forecast for the global inhaled nitric oxide by product type, application, and region.

Inhaled Nitric Oxide Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Gas
  • Delivery Systems

Inhaled Nitric Oxide Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Neonatal Respiratory Treatment
  • Asthma and COPD
  • Acute Respiratory Distress Syndrome
  • Malaria Treatment
  • Tuberculosis Treatment
  • Others

Inhaled Nitric Oxide Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Inhaled Nitric Oxide Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies inhaled nitric oxide companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the inhaled nitric oxide companies profiled in this report include-

  • Air Liquide Healthcare
  • BOC Healthcare
  • Matheson Tri-Gas
  • Merck
  • Mallinckrodt Pharmaceuticals
  • Nu-Med Plus
  • Perma Pure

Inhaled Nitric Oxide Market Insights

Lucintel forecasts that delivery systems is expected to witness the higher growth over the forecast period due to introduction of compact and portable delivery system, which enables for easier administration of nitric oxide therapy in various healthcare applications.

Within this market, asthma and COPD is expected to witness the highest growth due growing consumption of cigarettes, which contributes to asthma and COPD symptoms.

North America is expected to witness highest growth over the forecast period due to surging incidence of diseases like COPD and asthma, increasing aging population, and presence of major palyers in the region.

Features of the Global Inhaled Nitric Oxide Market

Market Size Estimates: Inhaled nitric oxide market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Inhaled nitric oxide market size by product type, application, and region in terms of value ($B).

Regional Analysis: Inhaled nitric oxide market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, applications, and regions for the inhaled nitric oxide market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the inhaled nitric oxide market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the inhaled nitric oxide market size?

Answer: The global inhaled nitric oxide market is expected to reach an estimated $1.1 billion by 2030.

Q2. What is the growth forecast for inhaled nitric oxide market?

Answer: The global inhaled nitric oxide market is expected to grow with a CAGR of 5.1% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the inhaled nitric oxide market?

Answer: The major drivers for this market are increasing prevalence of respiratory and other associated diseases along with ongoing research and development activities.

Q4. What are the major segments for inhaled nitric oxide market?

Answer: The future of the inhaled nitric oxide market looks promising with opportunities in the neonatal respiratory treatment, asthma and COPD, acute respiratory distress syndrome, malaria treatment, and tuberculosis treatment markets.

Q5. Who are the key inhaled nitric oxide market companies?

Answer: Some of the key inhaled nitric oxide companies are as follows:

  • Air Liquide Healthcare
  • BOC Healthcare
  • Matheson Tri-Gas
  • Merck
  • Mallinckrodt Pharmaceuticals
  • Nu-Med Plus
  • Perma Pure

Q6. Which inhaled nitric oxide market segment will be the largest in future?

Answer: Lucintel forecasts that delivery systems is expected to witness the higher growth over the forecast period due to introduction of compact and portable delivery system, which enables for easier administration of nitric oxide therapy in various healthcare applications.

Q7. In inhaled nitric oxide market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to surging incidence of diseases like COPD and asthma, increasing aging population, and presence of major palyers in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the inhaled nitric oxide market by product type (gas and delivery systems), application (neonatal respiratory treatment, asthma and COPD, acute respiratory distress syndrome, malaria treatment, tuberculosis treatment, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Inhaled Nitric Oxide Market: Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Inhaled Nitric Oxide Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Inhaled Nitric Oxide Market by Product Type
    • 3.3.1: Gas
    • 3.3.2: Delivery Systems
  • 3.4: Global Inhaled Nitric Oxide Market by Application
    • 3.4.1: Neonatal Respiratory Treatment
    • 3.4.2: Asthma and COPD
    • 3.4.3: Acute Respiratory Distress Syndrome
    • 3.4.4: Malaria Treatment
    • 3.4.5: Tuberculosis Treatment
    • 3.4.6: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Inhaled Nitric Oxide Market by Region
  • 4.2: North American Inhaled Nitric Oxide Market
    • 4.2.2: North American Inhaled Nitric Oxide Market by Application: Neonatal Respiratory Treatment, Asthma and COPD, Acute Respiratory Distress Syndrome, Malaria Treatment, Tuberculosis Treatment, and Others
  • 4.3: European Inhaled Nitric Oxide Market
    • 4.3.1: European Inhaled Nitric Oxide Market by Product Type: Gas and Delivery Systems
    • 4.3.2: European Inhaled Nitric Oxide Market by Application: Neonatal Respiratory Treatment, Asthma and COPD, Acute Respiratory Distress Syndrome, Malaria Treatment, Tuberculosis Treatment, and Others
  • 4.4: APAC Inhaled Nitric Oxide Market
    • 4.4.1: APAC Inhaled Nitric Oxide Market by Product Type: Gas and Delivery Systems
    • 4.4.2: APAC Inhaled Nitric Oxide Market by Application: Neonatal Respiratory Treatment, Asthma and COPD, Acute Respiratory Distress Syndrome, Malaria Treatment, Tuberculosis Treatment, and Others
  • 4.5: ROW Inhaled Nitric Oxide Market
    • 4.5.1: ROW Inhaled Nitric Oxide Market by Product Type: Gas and Delivery Systems
    • 4.5.2: ROW Inhaled Nitric Oxide Market by Application: Neonatal Respiratory Treatment, Asthma and COPD, Acute Respiratory Distress Syndrome, Malaria Treatment, Tuberculosis Treatment, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Inhaled Nitric Oxide Market by Product Type
    • 6.1.2: Growth Opportunities for the Global Inhaled Nitric Oxide Market by Application
    • 6.1.3: Growth Opportunities for the Global Inhaled Nitric Oxide Market by Region
  • 6.2: Emerging Trends in the Global Inhaled Nitric Oxide Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Inhaled Nitric Oxide Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Inhaled Nitric Oxide Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Air Liquide Healthcare
  • 7.2: BOC Healthcare
  • 7.3: Matheson Tri-Gas
  • 7.4: Merck
  • 7.5: Mallinckrodt Pharmaceuticals
  • 7.6: Nu-Med Plus
  • 7.7: Perma Pure